Innate Pharma SA
SWB:IDD
Innate Pharma SA
SWB:IDD
Price:
1.222
EUR
-1.77%
Market Cap:
€164.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
J
|
JELD-WEN Holding Inc
F:0JW
|
US |
|
E
|
Everbright Securities Co Ltd
HKEX:6178
|
CN |
|
A
|
Ad Pepper Media International NV
XMUN:APM
|
DE |
|
F
|
Fufeng Group Ltd
XMUN:FFO1
|
CN |
|
McEwen Mining Inc
F:US8
|
CA |
|
E
|
EnerSys
XMUN:FDN
|
US |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
